MedPath
FDA Approval

Flavoxate Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 25, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Flavoxate(100 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Flavoxate Hydrochloride

Product Details

NDC Product Code
54868-6326
Application Number
ANDA076835
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 25, 2012
dibasic calcium phosphate dihydrateInactive
Code: O7TSZ97GEPClass: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
FlavoxateActive
Code: 9C05J6089WClass: ACTIBQuantity: 100 mg in 1 1
silicon dioxideInactive
Code: ETJ7Z6XBU4Class: IACT
starch, cornInactive
Code: O8232NY3SJClass: IACT
hypromellosesInactive
Code: 3NXW29V3WOClass: IACT
polydextroseInactive
Code: VH2XOU12IEClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
triacetinInactive
Code: XHX3C3X673Class: IACT
© Copyright 2025. All Rights Reserved by MedPath